Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Mutations in the p53 tumor suppressor are the most frequently observed genetic alterations in human cancer. The majority of the mutations occur in the core domain which contains the sequence-specific DNA binding activity of the p53 protein (residues 102-292), and they result in loss of DNA binding. The crystal structure of a complex containing the core domain of human p53 and a DNA binding site has been determined at 2.2 angstroms resolution and refined to a crystallographic R factor of 20.5 percent. The core domain structure consists of a beta sandwich that serves as a scaffold for two large loops and a loop-sheet-helix motif. The two loops, which are held together in part by a tetrahedrally coordinated zinc atom, and the loop-sheet-helix motif form the DNA binding surface of p53. Residues from the loop-sheet-helix motif interact in the major groove of the DNA, while an arginine from one of the two large loops interacts in the minor groove. The loops and the loop-sheet-helix motif consist of the conserved regions of the core domain and contain the majority of the p53 mutations identified in tumors. The structure supports the hypothesis that DNA binding is critical for the biological activity of p53, and provides a framework for understanding how mutations inactivate it.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Modification of any of five arginine residues that are hotspots for TP53 mutations in human cancers disables TP53 sequence-specific DNA binding (Cho, et al., 1994).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Cho, et al., 1994
In the citing paper
“Gly-245 in the wild type adopts unusual backbone dihedral angles (1), which are not favored when the residue is replaced by serine.”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“The crystal structure of p53 core domain shows that the epitope of PAb240, located in strand 7, is inaccessible to antibody binding (1), and at least a partly unfolded form is required to expose the epitope.”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“The guanidinium group of Arg-249 is salt-bridged to the carboxylate group of Glu-171 in L2 and backbone oxygens of Gly-245 and Met-246 (1).”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“suggesting the structure of p53 core domain in solution is similar to that in crystal structure (1).”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Principles of Nucleic Acid Structure
Saenger, W. (1984) · Springer Advanced Texts in Chemistry · doi:10.1007/978-1-4612-5190-3 · Cited by 4,150
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Research works printed but not linked: 2
- SACK, J. S., JOURNAL OF MOLECULAR GRAPHICS 6: 224 (1988).
- TONRUD, D.E., ACTA CRYSTALLOGR A 43: 489 (1987).
Cited by
Items 1,701–1,800 of 2,517
Fiber-specific molecular features of tumors induced in rat peritoneum.
Unfried, K., Roller, M., POTT, F., et al. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51103 · Cited by 11
Giant leap for p53, small step for drug design
Anderson, M. E., & Tegtmeyer, P. (1995) · BioEssays · doi:10.1002/bies.950170103 · Cited by 11
Morton, M. S., Chan, P. S. F., Cheng, C., Blacklock, N., Matos-Ferreira, A., Abranches-Monteiro, L., Correia, R., Llyod, S., & Griffiths, K. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970701)32:2<122::aid-pros7>3.0.co;2-o · Cited by 244
Li, G., Tolstonog, G. V., Sabasch, M., & Traub, P. (2002) · DNA and Cell Biology · doi:10.1089/104454902760599726 · Cited by 11
“Nevertheless, cIF proteins bear a certain resemblance to the tumor suppressor protein p53, which interacts with both the major and minor grooves in DNA (Cho et al ., 1994).”
Sugikawa, E., Yazaki, N., Tsunoda, S., Nakanishi, N., & Ohashi, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1019 · Cited by 10
Molina, P., Pellín, A., Navarro, S., Boix, J., Cardá, C., & Llombart‐Bosch, A. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050446 · Cited by 11
“This region is not close to DNA, but can affect the structural integrity of the core domain, thus inactivating p53 most likely by unfolding of this structure [ 3 ].”
BackgroundThe Challenge of p53: Linking Biochemistry, Biology, and Patient Management
Bray, S. E., Schorl, C., & Hall, P. A. (1998) · Stem Cells · doi:10.1002/stem.160248 · Cited by 15
Cooperative Fluctuations Point to the Dimerization Interface of P53 Core Domain
Kantarci-Carsibasi, N., Doruker, P., & Haliloǧlu, T. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.077800 · Cited by 11
“Two regions that are known to have functional importance (10) are emphasized with black circles on the figure.”
BackgroundInfluentialCell biology, trace elements and nuclear microscopy
Lindh, U. (1995) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/0168-583x(95)00389-4 · Cited by 11
Privalov, P. (2012) · Wiley eBooks · doi:10.1002/9781118337509.ch12 · Cited by 11
Regulation of cell cycle progression following DNA damage
Hensey, C. E., & Gautier, J. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_12 · Cited by 11
Multi-helical DNA-binding domains: Their structures and modes of DNA-binding
Suzuki, M., SUCKOW, J. M., Kisters–Woike, B., Aramaki, H., & Marino, K. (1996) · Advances in Biophysics · doi:10.1016/0065-227x(96)84740-x · Cited by 11
Zhou, H., Zhang, Y., Ou-Yang, Z.-C., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4370 · Cited by 11
“In either case, they abrogate or modulate the ability of p53 to bind DNA (Cho et al., 1994).”
BackgroundReyes, J., Priore, I. S. D., Chaikovsky, A. C., Pasnuri, N., Elhossiny, A. M., Park, J., Weiler, P., Krause, T., Moorman, A. R., Snopkowski, C., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.032 · Cited by 21
Liu, Q., Li, L., Yu, Y., & Wei, G. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c04700 · Cited by 11
Profile and Frequency of p53 Gene Alterations in Gastritis Lesions from Iran
Sadeghi, R. N., Azimzadeh, P., Vahedi, M., Mirsattari, D., Molaei, M., Mohebbi, S. R., Zojaji, H., Fatemi, S. R., & Zali, M. R. (2010) · Digestion · doi:10.1159/000320690 · Cited by 11
The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming
Shoae‐Hassani, A., Sharif, S., & Verdi, J. (2011) · Cell Biology International · doi:10.1042/cbi20100927 · Cited by 11
“Withdrawal of DHEA increases the levels of p53 in the epithelial and stromal cells of the rat ventral prostate, resulting in increased levels of apoptotic cells (Cho et al., 1994).”
BackgroundSobeh, M., & Kitao, A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01508 · Cited by 11
Jagošová, J., Pitrová, L., Slováčková, J., Ravčuková, B., Šmarda, J., & Šmardová, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1520 · Cited by 12
Three‐Pronged Probes: High‐Affinity DNA Binding with Cap, β‐Alanines and Oligopyrrolamides
Haug, R., Krämer, M., & Richert, C. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201302972 · Cited by 10
Hainaut, P. L., Wiman, K. G., & Olivier, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8 · Cited by 10
Hébert‐Magee, S., Yu, H., Behring, M. P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211734 · Cited by 10
Structural-functional diversity of p53 proteoforms
Naryzhny, S., & Legina, O. K. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196504263 · Cited by 10
Meher, R. K., Mir, S. A., & Anisetti, S. S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2219323 · Cited by 10
“Since there is no co-crystal molecule complexed with 1tup PDB retrieved from the online database (Cho et al ., 1994).”
MethodTracing the protectors path from the germ line to the genome
Coutandin, D., Ou, H. D., Löhr, F., & Dötsch, V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001069107 · Cited by 11
Kim, S., Yu, J.-G., Lee, G.-H., & Park, Y. (2012) · Horticulture Environment and Biotechnology · doi:10.1007/s13580-012-0084-5 · Cited by 11
“The resolved DNA was then blotted onto a nylon membrane (HybondN + , Amersham, UK) using the standard procedure of Cho et al. (1994).”
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines
Wasielewski, M., Hanifi-Moghaddam, P., Hollestelle, A., Merajver, S. D., van den Ouweland, A., Klijn, J. G. M., Ethier, S. P., & Schutte, M. E. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9942-3 · Cited by 11
“Two of five mutant CHEK2 cell lines also had a heterozygous p53 sequence alteration (Table 4). Cell line LNCaP carried the silent p53 P152P polymorphism and cell line HCT15 had the p53 S241F missense mutation that is likely oncogenic as this residue is crucial for interaction of wild-type p53 proteins with DNA [15, 20…”
BackgroundActivité dominante négative des protéines p53 mutées
Dridi, W., Krabchi, K., Gadji, M., Lavoie, J., Bronsard, M., Fetni, R., & Drouin, R. (2006) · médecine/sciences · doi:10.1051/medsci/2006223301 · Cited by 10
“La conséquence immédiate est une absence totale d’activité transcriptionnelle [6].”
BackgroundInfluentialOh, S., Jung, J., Shim, S.-S., Im, M.-Y., Kim, H., Chung, S.-Y., & Yoon, J. (2000) · Molecules and Cells · doi:10.1016/s1016-8478(23)17475-9 · Cited by 10
Structural Studies on Mechanisms to Activate Mutant p53
Viadiu, H., Fronza, G., & Inga, A. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_7 · Cited by 9
The inhibitory action of long‐chain fatty acids on the DNA binding activity of p53
Iijima, H., Kasai, N., Chiku, H., et al. (2006) · Lipids · doi:10.1007/s11745-006-5000-2 · Cited by 10
“The structure of the DNA binding domain consists of a large β-sandwich that acts as a scaffold for three loop-based elements that contact the DNA ( 5 ).”
BackgroundInfluentialStructural Similarity between Histone Chaperone Cia1p/Asf1p and DNA-Binding Protein NF-κB
Padmanabhan, B., Kataoka, K., Umehara, T., Adachi, N., Yokoyama, S., & Horikoshi, M. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi182 · Cited by 12
Jäckel, M. C., Sellmann, L., Youssef, S., et al. (2001) · HNO · doi:10.1007/s001060050734 · Cited by 10
“Mutationen, die unmittelbar die DNA-Bindungsdomäne des Proteins betreffen (‘Kontaktmutationen’), scheinen mit einem ungünstigeren klinischen Verlauf von Kopf-Hals-Karzinomen assoziiert zu sein, als Mutationen in anderen Bereichen des Proteins (‘Strukturmutationen’), [3, 5].”
BackgroundEklund, L. K., Lindström, E., Undén, A. B., Lundh-Rozell, B., Ståhle‐Bäckdahl, M., Zaphiropoulos, P. G., Toftgård, R., & Söderkvist, P. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199802)21:2<93::aid-mc3>3.0.co;2-p · Cited by 23
Precise mapping of the tms1 binding site on p53
Wagner, P., Fuchs, A., Prowald, A., Montenarh, M., & Nastainczyk, W. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01329-6 · Cited by 11
Module 4: Sensors and Effectors
Berridge, M. J. (2012) · Cell Signalling Biology · doi:10.1042/csb0001004 · Cited by 11
Navigating the complexity of p53-DNA binding: implications for cancer therapy
Thayer, K. M., Stetson, S., Caballero, F., Chiu, C., & Han, I. S. M. (2024) · Biophysical Reviews · doi:10.1007/s12551-024-01207-4 · Cited by 11
“The core of the protein was first crystallized in 1994 (PDBID 1TUP) by Cho et al. (1994) providing considerable atomic level detail of the structure of the protein and its interaction with an engineered consensus DNA sequence.”
BackgroundResultInfluentialStructural biology in variant interpretation: Perspectives and practices from two studies
Varga, M. J., Richardson, M. E., & Chamberlin, A. C. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.03.010 · Cited by 11
Protein–protein interactions of ASPP2: an emerging therapeutic target
Iosub‐Amir, A., & Friedler, A. (2014) · MedChemComm · doi:10.1039/c4md00147h · Cited by 9
Qiu, P., Jie, Y., Ma, C., Chen, H., Qin, Y., Tu, K., Wang, L., & Zhang, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01072-8 · Cited by 10
“M246V), and both of them were likely oncogenic [15, 16].”
BackgroundIanni, A. D., Tüting, C., Kipping, M., Ihling, C. H., Köppen, J., Iacobucci, C., Arlt, C., Kastritis, P. L., & Sinz, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-35437-5 · Cited by 10
Engagement of intrinsic disordered proteins in protein–protein interaction
Roterman, I., Stąpor, K., & Konieczny, L. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1230922 · Cited by 9
Oak, S., Karajgikar, O., & Teni, T. R. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.08.016 · Cited by 10
Three Assays Show Differences in Binding of Wild-Type and Mutant p53 to Unique Gene Sequences
Chandrachud, U., & Gal, S. (2009) · Technology in Cancer Research & Treatment · doi:10.1177/153303460900800606 · Cited by 9
Chromatin structure related to oncogenesis
Matsumoto, S., Horikoshi, N., Takizawa, Y., & Kurumizaka, H. (2023) · Cancer Science · doi:10.1111/cas.15850 · Cited by 8
Big versus small: The impact of aggregate size in disease
Hnath, B., Chen, J., Reynolds, J., Choi, E. S., Wang, J., Zhang, D., Sha, C. M., & Dokholyan, N. V. (2023) · Protein Science · doi:10.1002/pro.4686 · Cited by 8
“They analyzed the secondary structure and found that Aβ42 peptide conformations are dominated by loops and turns but show some helical structure in the C-terminal hydrophobic tail (Baumketner, 2006).”
BackgroundInfluentialPivoňková, H., Pečínka, P., Češková, P., & Fojta, M. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05472.x · Cited by 9
Kakinoki, Y., Kubota, H., Sakurai, H., et al. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05017 · Cited by 9
“Most mutations in the p53 gene have been found in the DNA-binding domain (exons 5-8) [ 10 ].”
Background5-Methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation
Monti, P., Inga, A., Scott, G. B., Aprile, A., Campomenosi, P., Menichini, P., Ottaggio, L., Viaggi, S., Abbondandolo, A., Burns, P. A., et al. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00187-6 · Cited by 9
Selective transcription of p53 target genes by zinc finger–p53 DNA binding domain chimeras
Falke, D., Fisher, M. H., & Juliano, R. L. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.09.011 · Cited by 9
How Cardiomyocytes Make the Heart Old
Papp, Z. L., Czuriga, D., Balogh, L., Balogh, A., & Borbély, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112804583104 · Cited by 11
Molecular analysis of Ceruloplasmin in a South African cohort presenting with oesophageal cancer
Strickland, N. J., Matsha, T. E., Erasmus, R., & Zaahl, M. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26418 · Cited by 11
Transduction of Recombinant M3-p53-R12 Protein Enhances Human Leukemia Cell Apoptosis
Lu, T.-C., Zhao, G. H., Chen, Y. Y., Chien, C.-Y., Huang, C.-H., Lin, K., & Chen, S. L. (2016) · Journal of Cancer · doi:10.7150/jca.15155 · Cited by 9
“Zinc ion is crucial for the folding and stabilization of p53 and it also contribute to the DNA-binding activity of p53 [5, 6].”
BackgroundHsu, S., Lin, P., Chou, C., & Lee, W. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.08.011 · Cited by 9
Kobren, S. N., Chazelle, B., & Singh, M. (2020) · Cell Systems · doi:10.1016/j.cels.2020.06.005 · Cited by 10
“Whereas some specific mutations within interaction sites have been linked to oncogenic activity (Stehr et al., 2011), other binding site mutations are known to entirely disrupt critical interactions and overall protein function (Cho et al., 1994).”
The First Twenty-Five Years of p53 Research
Robins, H. S., Alexe, G., Harris, S. L., & Levine, A. J. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_1 · Cited by 11
Adámik, M., Bažantová, P., Navrátilová, L., Polášková, A., Pečínka, P., Holaňová, L., Tichý, V., & Brázdová, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.027 · Cited by 9
“p53 family belongs to metalloproteins, a zinc ion coordination in DBD by three cysteines and one histidine is necessary for DNA binding of all family members [2,3,7–9].”
Backgroundp53: Balancing tumour suppression and implications for the clinic
Buganim, Y., & Rotter, V. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70037-1 · Cited by 10
Two TP53 germline mutations in a classical Li-Fraumeni syndrome family
van Hest, L. P., Ruijs, M., Wagner, A., van der Meer, C. A., Verhoef, S., Veer, L. J. V., & Meijers-Heijboer, H. E. J. (2007) · Familial Cancer · doi:10.1007/s10689-006-9115-7 · Cited by 9
“Although generally codon 100‐300 is called the DNA binding domain, codon 235 is not directly involved in DNA-binding; it is located in between two domains that interact extensively to provide DNA contacts [ 20 ].”
BackgroundProgrammed cell death is not mediated by a p53 homolog in Pisum sativum
Klosterman, S. J., Choi, J. J., & Hadwiger, L. A. (2000) · Physiological and Molecular Plant Pathology · doi:10.1006/pmpp.2000.0267 · Cited by 9
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan
Amikura, T., Sekine, M., Hirai, Y., Fujimoto, S., Hatae, M., Kobayashi, I., Fujii, T., Nagata, I., Ushijima, K., 小畑, 孝., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.09.010 · Cited by 9
How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?
Taubert, H. W., Berger, D., Hinze, R., et al. (1998) · Cancer Letters · doi:10.1016/s0304-3835(97)00423-0 · Cited by 9
“Both p53 mutations concern either functionally (codon 275) or structurally (codon 175) the interaction p53 protein/DNA, suggesting a disturbance of p53 activity as the transcription factor [4].”
BackgroundLeng, K., Schlien, S., & Bosch, F. X. (2005) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2005.00365.x · Cited by 9
Patterns of TP53 Mutations in Human Cancer: Interplay Between Mutagenesis, DNA Repair and Selection
Shi, H., Calvez‐Kelm, F. L., Olivier, M., & Hainaut, P. L. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_13 · Cited by 9
Ritchie, A., & Broxmeyer, H. E. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00018-9 · Cited by 9
“loop III within the core DNA-binding domain [189].”
BackgroundSomatic mutations in human cancer: applications in molecular epidemiology
Roux, E. L., Gormally, E., & Hainaut, P. L. (2005) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(05)84603-6 · Cited by 8
Marchenko, N. D., & Moll, U. M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90051-4 · Cited by 9
TP53 as clinical marker in head and neck cancer
Peltonen, J. K. (2011) · Cited by 9
The p53 protein – not only the guardian of the genome
Rusin, M. (2024) · Postępy Biochemii · doi:10.18388/pb.2021_518 · Cited by 13
“Its three-dimensional structure was determined, and it was discovered that this fragment is well-structured, with the zinc atom playing an important part in stabilizing the conformation [9].”
BackgroundZhao, Z., Wang, G., Wu, X., & Qian, Z. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp01257k · Cited by 8
TP53 ‐Mutated Acute Myeloid Leukemia: Unanswered Questions
Bruzzese, A., Vigna, E., Martino, E. A., Labanca, C., Caridà, G., Mendicino, F., Lucia, E., Olivito, V., Puccio, N., Neri, A., et al. (2025) · Hematological Oncology · doi:10.1002/hon.70106 · Cited by 12
Targeting p53 activation: Recent therapeutic advances in cancer and diabetic macular edema
Wang, Z., Zhang, S., Mélita, I. L., & Zhao, Y. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117909 · Cited by 12
Xu, J., Zhang, Z., Wei, J., Zhu, Y., Zhao, D., Xia, T., Liu, X., Wang, C., & Gong, B. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00708-0 · Cited by 14
“T + BD-Lam) served as positive and negative controls, respectively (Cho et al, 1994).”
Response of the Urothelial Carcinoma Cell Lines to Cisplatin
Holíčková, A., Roška, J., Órásová, E., Bruderová, V., Palacka, P., Jurkovičová, D., & Chovanec, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012488 · Cited by 8
Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Chachad, D., Patel, L. R., Recio, C. V., Pourebrahim, R., Whitley, E. M., Wang, W., Su, X., Xu, A., Lee, D., & Lozano, G. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3464 · Cited by 9
Okuş, F., Yüzbaşıoğlu, D., & Ünal, F. (2023) · Toxicology · doi:10.1016/j.tox.2023.153716 · Cited by 8
Antioxidant agents transiently inhibit aneuploidy progression in Li‐Fraumeni cell strains
Kraniak, J. M., Abrams, J., Nowak, J. E., & Tainsky, M. A. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20145 · Cited by 8
“MDAH172, a conformation mutant [55], has a single base substitution at codon 175 (CGC to CAC or Arg to His)”
BackgroundMultipattern Consensus Regions in Multiple Aligned Protein Sequences and Their Segmentation
Chiu, D., & Wang, Y. (2006) · EURASIP Journal on Bioinformatics and Systems Biology · doi:10.1155/bsb/2006/35809 · Cited by 9
“It is known that the majority of the p53 mutations occur in the core domain, see Cho et al. [25]; Greenblatt et al. [6]; Hamroun et al. [26].”
BackgroundRauf, S. M. A., Ismael, M., Sahu, K. K., Suzuki, A., Koyama, M., Tsuboi, H., Hatakeyama, N., Endou, A., Takaba, H., Carpio, C. A. D., et al. (2010) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2010.03.004 · Cited by 7
Human transcription factors in yeast: the fruitful examples of P53 and NF-кB
Sharma, V., Monti, P., Fronza, G., & Inga, A. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow083 · Cited by 11
Fluorescent Biosensor for Detection of the R248Q Aggregation‐Prone Mutant of p53
Pellerano, M., Naud‐Martin, D., Mahuteau‐Betzer, F., Morille, M., & Morris, M. C. (2018) · ChemBioChem · doi:10.1002/cbic.201800531 · Cited by 9
Protodomains: Symmetry-Related Supersecondary Structures in Proteins and Self-Complementarity
Youkharibache, P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9161-7_10 · Cited by 9
Disorder for Dummies: Functional Mutagenesis of Transient Helical Segments in Disordered Proteins
Daughdrill, G. W. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0524-0_1 · Cited by 8
p53 Is Potentially Regulated by Cyclophilin D in the Triple-Proline Loop of the DNA Binding Domain
Kumutima, J., Yao, X., & Hamelberg, D. (2021) · Biochemistry · doi:10.1021/acs.biochem.0c00946 · Cited by 9
Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells
Indukuri, R., Hases, L., Archer, A., & Williams, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.650625 · Cited by 13
Ezoji, H., Rahimnejad, M., & Najafpour, G. D. (2021) · Measurement · doi:10.1016/j.measurement.2021.109977 · Cited by 8
Annor, G. K., Elshabassy, N., Lundine, D., Conde, D.-G., Xiao, G., Ellison, V., & Bargonetti, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772315 · Cited by 10
“Amino acids in the central region of wild-type p53 form direct DNA contacts and conformationally coordinate the protein for stable sequence-specific interactions at p53 response elements; the hotspot cancer amino acid mutations in Arg 248 (R248) and Arg 273 (R273) correspond to amino acid residues that make direct con…”
BackgroundAl-Kashwan, T. A. J., Houshmand, M., Al-Janabi, A., Melconian, A. K., Al-Abbasi, D., Al-Musawi, M. N., Rostami, M., & Yasseen, A. A. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-466 · Cited by 8
“In total, about 40% of them are localized at the "hotspot" residues R 175, G 245, R 248, R 249, R 273 and R 282 [14].”
BackgroundTu, C., Tan, Y.-H., Shaw, G., Zhou, Z., Bai, Y., Luo, R., & Ji, X. (2008) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444908003338 · Cited by 8
“Thus, the flexibility of L1 may be important for the DNA-binding activity of p53 because residue Lys120, which is located at the apex of L1, is involved in the sequence-specific central recognition of DNA (Cho et al., 1994; Kitayner et al., 2006).”
BackgroundInfluentialVariaciones genéticas del gen supresor de tumores TP53: relevancia y estrategias de análisis
Rangel-López, A., Piña‐Sánchez, P., & Salcedo, M. (2006) · Revista de investigaci�n Cl�nica · Cited by 8
Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties
Omar, S. I., & Tuszyński, J. A. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12480 · Cited by 8
“The 1TSR-B (41) wild-type p53-DNA complex crystal structure co-ordinates were obtained from the”
MethodUse of transcription factors as agents and targets for drug development.
Lm, S., & Mj, B. (1996) · PubMed · Cited by 8
Sarma, P. P., Dutta, D., Mirza, Z., et al. (2017) · PubMed · doi:10.7868/s0026898417020185 · Cited by 8
Bizzarri, A. R., & Cannistraro, S. (2020) · Biomolecules · doi:10.3390/biom10020346 · Cited by 8
“The structure of DBD to make the DBD-miR4749 complex was derived from the B chain of DBD in complex with a consensus DNA (1 TUP entry from the protein data bank) [11].”
BackgroundMeng, D., Guo, K., Zhang, D., Zhao, C., Sun, C., & Zhang, F. (2021) · Oncology Letters · doi:10.3892/ol.2021.12697 · Cited by 10
Bhattacharjee, S., & Sengupta, J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.08.037 · Cited by 8
Koulgi, S., Achalere, A., Sonavane, U., & Joshi, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143065 · Cited by 8
“This DBD region consists of a loop-sheet-helix motif and two large loops tethered by a zinc ion (Fig 1A) [11].”
BackgroundPathways of p53-Dependent Apoptosis
Grasso, L., & Mercer, W. E. (1997) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60706-2 · Cited by 11
Jackson, P., Shield, M. A., Buskin, J. N., Hawkes, S. P., Reed, M. J., Perrem, K., Hauschka, S. D., & Braithwaite, A. W. (1995) · Europe PMC (PubMed Central) · Cited by 8
Dihedral-Angle Information Entropy as a Gauge of Secondary Structure Propensity
Zhong, S., Moix, J. M., Quirk, S., & Hernandez, R. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.089243 · Cited by 7
“The HIV envelope glycoprotein (1g9nG) (56), the p53 DNA binding domain (1tupA) (57), and the G-protein a-1 chain (1gg2A) (58) are fairly common proteins whose structures have been resolved and deposited in the PDB.”
Background
Metadata
- Authors
- Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Venue
- Science
- Published
- 1994-07-15
- Volume
- 265
- Issue
- 5170
- Pages
- 346-355
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2096276671
- Semantic Scholar
- 11096f3b08e172ce5e261795b6749818ee59c03d
- Cited by
- 2,551
- References
- 62
- Citations by year
- 2026: 62 · 2025: 52 · 2024: 40 · 2023: 64 · 2022: 61 · 2021: 73 · 2020: 67 · 2019: 62 · 2018: 61 · 2017: 54 · 2016: 64 · 2015: 62 · 2014: 81 · 2013: 78 · 2012: 68
- FWCI
- 64.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- National Cancer Institute (NCI CA08748-29)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- p53 tumor suppressor, p53 core domain, DNA binding, zinc coordination, beta-sandwich, cancer genetics
- MeSH terms
- Amino Acid Sequence, Base Sequence, Binding Sites, Computer Graphics, Crystallization, DNA, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Protein Conformation, Genes, p53, Tumor Suppressor Protein p53, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.